(Q39039478)

English

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

scientific article published on July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection (English)

1 reference

Europe PubMed Central

8 September 2017

0 references

liver cirrhosis

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

object named as

Takashi Kumada

1 reference

Europe PubMed Central

8 September 2017

Hidenori Toyoda

1

object named as

Hidenori Toyoda

1 reference

Europe PubMed Central

8 September 2017

3

object named as

Toshifumi Tada

1 reference

Europe PubMed Central

8 September 2017

9

object named as

Takanori Ito

1 reference

Europe PubMed Central

8 September 2017

4

object named as

Seiki Kiriyama

1 reference

Europe PubMed Central

8 September 2017

Makoto Tanikawa

5

object named as

Makoto Tanikawa

1 reference

Europe PubMed Central

8 September 2017

Yasuhiro Hisanaga

6

object named as

Yasuhiro Hisanaga

1 reference

Europe PubMed Central

8 September 2017

7

object named as

Akira Kanamori

1 reference

Europe PubMed Central

8 September 2017

Shusuke Kitabatake

8

object named as

Shusuke Kitabatake

1 reference

Europe PubMed Central

8 September 2017

publication date

1 July 2015

1 reference

Europe PubMed Central

8 September 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

8 September 2017

30

1 reference

Europe PubMed Central

8 September 2017

1183-1189

1 reference

Europe PubMed Central

8 September 2017

7

1 reference

Europe PubMed Central

8 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Viral hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Preliminary study of two antiviral agents for hepatitis C genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Sofosbuvir for previously untreated chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Faldaprevir and deleobuvir for HCV genotype 1 infection.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Standards of medical care in diabetes--2010.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12915

21 January 2018

Identifiers

10.1111/JGH.12915

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39039478&oldid=1859137691"